Scarica l'app Stockscreener
33.62
7.76%
2.42
Dopo l'orario di chiusura:
33.55
-0.07
-0.21%
Rapt Therapeutics Inc Borsa (RAPT) Ultime notizie
Piper Sandler initiates coverage on Rapt Therapeutics stock with Overweight rating - Investing.com UK
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
Will RAPT Therapeutics Inc. (0RA0) stock benefit from Fed rate cutsMarket Sentiment Review & Low Volatility Stock Suggestions - ulpravda.ru
RAPT Therapeutics to Present Company Overview at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Rapt Therapeutics (NASDAQ:RAPT) Trading Down 4%Should You Sell? - MarketBeat
Can RAPT Therapeutics Inc. stock sustain institutional interestSupport and Resistance Levels & Budget Friendly Trading Ideas - bollywoodhelpline.com
RAPT Therapeutics (RAPT) Is Up 8.0% After Index Additions And Trial Progress News Has The Bull Case Changed? - simplywall.st
RAPT Therapeutics (RAPT) Joins Key Biotech Index Is Its Investor Story Entering a New Phase? - Yahoo Finance
Rapt Therapeutics (NASDAQ:RAPT) Trading 9.8% HigherWhat's Next? - MarketBeat
RAPT Therapeutics, Inc.(NasdaqGM:RAPT) added to S&P Biotechnology Select Industry Index - marketscreener.com
Can RAPT Therapeutics Inc. (0RA0) stock resist broad market declinesQuarterly Growth Report & Safe Entry Zone Identification - Улправда
TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy” - Insider Monkey
TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a "Buy" - Finviz
Certain Pre Funded warrants of RAPT Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2025. - marketscreener.com
Certain Options of RAPT Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2025. - marketscreener.com
Certain Common Stock of RAPT Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2025. - marketscreener.com
Is RAPT Therapeutics Inc. (0RA) stock a top dividend aristocrat candidateRisk Management & Free Daily Entry Point Trade Alerts - Улправда
Will RAPT Therapeutics Inc. stock outperform value stocksJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - Улправда
Rapt Therapeutics (NASDAQ:RAPT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
12 Best Multibagger Stocks to Buy Heading into 2026 - Insider Monkey
Will RAPT Therapeutics Inc. stock deliver long term returnsJuly 2025 Trends & Free Community Consensus Stock Picks - Улправда
Is RAPT Therapeutics Inc. (0RA) stock among top earnings playsMarket Performance Summary & Stepwise Swing Trade Plans - ulpravda.ru
Rapt Therapeutics (NASDAQ:RAPT) Now Covered by TD Cowen - Defense World
Published on: 2025-12-19 09:56:31 - Улправда
How RAPT Therapeutics Inc. stock benefits from global expansionWeekly Stock Recap & AI Driven Stock Movement Reports - Улправда
Published on: 2025-12-19 01:07:45 - Улправда
Why analysts maintain buy rating on RAPT Therapeutics Inc. (0RA0) stockInsider Buying & Accurate Buy Signal Alerts - Улправда
Rapt Therapeutics (NASDAQ:RAPT) Shares Gap UpStill a Buy? - MarketBeat
Will RAPT Therapeutics Inc. stock maintain dividend yieldJuly 2025 Gainers & Real-Time Buy Signal Notifications - ulpravda.ru
TD Cowen Initiates Coverage on RAPT Therapeutics With Buy Rating - marketscreener.com
Rapt Therapeutics (NASDAQ:RAPT) Coverage Initiated at TD Cowen - MarketBeat
TD Cowen initiates coverage on Rapt Therapeutics stock with Buy rating - Investing.com Canada
Rapt Therapeutics (NASDAQ:RAPT) Stock Price Down 9.2%Should You Sell? - MarketBeat
RAPT Therapeutics, Inc. (NASDAQ:RAPT) surges 5.3%; individual investors who own 34% shares profited along with institutions - Yahoo Finance
Rapt Therapeutics (NASDAQ:RAPT) Trading Up 4.9%Here's Why - MarketBeat
BVF Inc. IL Trims Holdings in Rapt Therapeutics $RAPT - MarketBeat
RAPT Therapeutics Announces Major Public Stock Offering - MSN
Rapt Therapeutics $RAPT Shares Sold by Redmile Group LLC - MarketBeat
Can RAPT Therapeutics Inc. (0RA) stock deliver strong annual returnsMarket Risk Summary & Growth Focused Investment Plans - Newser
Published on: 2025-12-04 13:14:54 - Newser
How RAPT Therapeutics Inc. (0RA) stock compares with tech leadersPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
How robust is RAPT Therapeutics Inc. (0RA) stock financial positionVolume Spike & Risk Managed Trade Strategies - Newser
Does RAPT Therapeutics Inc (RAPT) offer a good opportunity for investors? - Setenews
Can RAPT Therapeutics Inc. (0RA0) stock sustain margin levels2025 Biggest Moves & Fast Moving Market Watchlists - Newser
What macro factors could drive RAPT Therapeutics Inc. (0RA0) stock higherRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Why RAPT Therapeutics Inc. (0RA) stock is trending on social mediaFed Meeting & Safe Capital Allocation Plans - Newser
How RAPT Therapeutics Inc. (0RA0) stock performs in easing cyclesRisk Management & Technical Pattern Based Buy Signals - Newser
Published on: 2025-12-02 05:12:24 - Newser
Can RAPT Therapeutics Inc. (0RA) stock ride next bull market cycle2025 Big Picture & Growth Oriented Trade Recommendations - Newser
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):